Carmichael Hill & Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $23.4K | Hold |
45
| – | – | 0.01% | 399 |
|
|
2024
Q2 | $24.4K | Hold |
45
| – | – | 0.01% | 380 |
|
|
2024
Q1 | $23.3K | Hold |
45
| – | – | 0.01% | 387 |
|
|
2023
Q4 | $21.2K | Hold |
45
| – | – | 0.01% | 387 |
|
|
2023
Q3 | $19.6K | Hold |
45
| – | – | 0.01% | 384 |
|
|
2023
Q2 | $20K | Hold |
45
| – | – | 0.01% | 390 |
|
|
2023
Q1 | $20.7K | Hold |
45
| – | – | 0.01% | 381 |
|
|
2022
Q4 | $23.1K | Hold |
45
| – | – | 0.01% | 357 |
|
|
2022
Q3 | $20K | Hold |
45
| – | – | 0.01% | 380 |
|
|
2022
Q2 | $22K | Hold |
45
| – | – | 0.01% | 364 |
|
|
2022
Q1 | $22K | Hold |
45
| – | – | 0.01% | 389 |
|
|
2021
Q4 | $21K | Hold |
45
| – | – | 0.01% | 403 |
|
|
2021
Q3 | $17K | Hold |
45
| – | – | 0.01% | 421 |
|
|
2021
Q2 | $17K | Sell |
45
-2
| -4% | -$756 | 0.01% | 426 |
|
|
2021
Q1 | $17K | Hold |
47
| – | – | 0.01% | 414 |
|
|
2020
Q4 | $15K | Hold |
47
| – | – | 0.01% | 418 |
|
|
2020
Q3 | $13K | Buy |
47
+11
| +31% | +$3.04K | 0.01% | 402 |
|
|
2020
Q2 | $9K | Hold |
36
| – | – | 0.01% | 424 |
|
|
2020
Q1 | $8K | Hold |
36
| – | – | 0.01% | 416 |
|
|
2019
Q4 | $11K | Buy |
+36
| New | +$11K | 0.01% | 410 |
|